SCHEMBL25832158

SCHEMBL25832158

CN[C@H](C)c1ccc(Br)c(F)c1C

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.33
SLC6A4 P31645 5/20 0.33
KCNH2 Q12809 4/20 0.33
CYP2D6 P10635 1/20 0.32
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12533397 0.80 TRPA1 (0.33)
SCHEMBL23113991 0.80 HTT (0.38) ALDH1A1
SCHEMBL18854486 0.78
SCHEMBL26051013 0.78
SCHEMBL18854484 0.78
SCHEMBL18862618 0.78
SCHEMBL18862370 0.78
SCHEMBL31739175 0.77
SCHEMBL18854482 0.77 PDE2A (0.38) KCNH2CYP2D6
SCHEMBL31739098 0.77 METAP2 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125907-A1 DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE BEIGENE, LTD. (KY) 2023-07-06 WO disclosed